Luna Collaborates with Scripps to Expand Health System At-Home Care Services
On-demand physical therapy provider to enable in-person, outpatient delivery for Scripps patients SAN DIEGO and…
Staff
Brickell Biotech To Host Key Opinion Leader Webinar on the Hyperhidrosis Market
Webinar taking place on Friday, March 26th @ 10 am EDT BOULDER, Colo., March 05,…
Keros Therapeutics Presents Results from Preclinical Studies of KER-050 and ALK2 Inhibitors at the European School of Haematology (ESH) 2nd Translational Research E-Conference
LEXINGTON, Mass., March 05, 2021 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…
Agile Therapeutics to Present at Upcoming March Investor Conferences
PRINCETON, N.J., March 05, 2021 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare…
Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021
DURHAM, N.C., March 05, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc., a clinical-stage biotechnology platform company…
Psyence Group Announces Partnership With Base Pair Health and Strengthens Management Team
TORONTO, March 05, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the…
Tauriga Sciences Inc. Selects First Foods Group, Inc. to Manufacture its New, Full Spectrum CBD Infused Product Line
Tauriga 03-05-2021 Full Spectrum CBD Infused Chocolate Bites This Full Spectrum CBD Infused Product Line…
LifeMD Q1 2021 Revenues on Track to Exceed $17 Million, up 295%, with Subscriptions Representing More than 80% of Total Revenue
NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) — LifeMD, Inc. (NASDAQ: LFMD) (formerly Conversion Labs),…
Sigilon Therapeutics Receives Orphan Drug Designation for SIG-007 for the Treatment of Fabry Disease
CAMBRIDGE, Mass., March 05, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company…
Imara Reports Full Year 2020 Financial Results and Business Highlights
Significant progress advancing IMR-687 as an oral, once-a-day potentially disease modifying treatment for sickle cell…